Back to Search
PAUL TEIRSTEIN, M.D.
M.D.
Interventional Cardiology Physician
NPI: 1548210768IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
G52018(CA)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
G52018(CA)
CMS Specialties
PrimaryINTERVENTIONAL CARDIOLOGY
Additional
CARDIOVASCULAR DISEASE (CARDIOLOGY)INTERNAL MEDICINE
Education
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Class of 1980
Clinical Trials (2)
2
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Percutaneous revascularization is the preferred strategy for patients with significant left main coronary stenosis.
PMID 19237673·Circulation·2009
8-other
Unprotected left main intervention: patient selection, operator technique, and clinical outcomes.
PMID 19393138·JACC Cardiovasc Interv·2008
6-review
Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization.
PMID 16563920·Am J Cardiol·2006
4-observational
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
PMID 16098300·Am J Cardiol·2005
3-trial
A chicken in every pot and a drug-eluting stent in every lesion.
PMID 15117858·Circulation·2004
5-case
Vascular radiation in a drug-eluting stent world: it's not over till it's over.
PMID 12885730·Circulation·2003
4-observational
Late stent thrombosis in brachytherapy: the role of long-term antiplatelet therapy.
PMID 11870263·J Invasive Cardiol·2002
6-review
New frontiers in interventional cardiology: intravascular radiation to prevent restenosis.
PMID 11714660·Circulation·2001
6-review
Radiation therapy to inhibit restenosis: early clinical results.
PMID 11373691·Mt Sinai J Med·2001
3-trial
Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial.
PMID 10653825·Circulation·2000
3-trial
Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.
PMID 19389558·J Am Coll Cardiol·2009
4-observational
Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.
PMID 19628179·JACC Cardiovasc Interv·2009
3-trial
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
PMID 19463408·JACC Cardiovasc Interv·2009
4-observational
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
PMID 19463464·JACC Cardiovasc Interv·2009
4-observational
Safety and performance of targeted renal therapy: the Be-RITe! Registry.
PMID 19281283·J Endovasc Ther·2009
4-observational
Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial).
PMID 19327416·Am J Cardiol·2009
4-observational
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.
PMID 19376306·Am Heart J·2009
4-observational
Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention.
PMID 19427425·Am J Cardiol·2009
8-other
3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
PMID 19463342·JACC Cardiovasc Interv·2008
4-observational
Quality of life with PCI versus medical therapy in stable coronary disease.
PMID 19031543·N Engl J Med·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9898 GENESEE AVE
LA JOLLA, CA 92037 - Phone
- (858) 824-5222
Quick Facts
- NPI
- 1548210768
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 46
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile